Stemtech (STEK) Cost of Revenue (2021 - 2025)

Stemtech has disclosed Cost of Revenue across 5 years of filings, most recently posting $33294.0 for Q4 2025.

• Cost of Revenue for Q4 2025 came in at $33294.0, up 103.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $339565.0 (up 221.67% YoY), and the FY2025 annual result was $496802.0, up 351.92% from the prior year.
• Cost of Revenue came in at $33294.0 for Q4 2025 at Stemtech, down from $161756.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $718884.0 in Q4 2021 to a low of -$947820.0 in Q4 2024.
• The 5-year median for Cost of Revenue is $170950.5 (2021), against an average of $105079.7.
• Across the five-year window, Cost of Revenue plunged 135.63% in 2022 and jumped 635.39% in 2025, its largest moves.
• Stemtech's Cost of Revenue stood at $718884.0 in 2021, then slumped by 135.63% to -$256169.0 in 2022, then sank by 75.5% to -$449578.0 in 2023, then slumped by 110.82% to -$947820.0 in 2024, then jumped by 103.51% to $33294.0 in 2025.
• The last three Cost of Revenue figures came in at $33294.0 (Q4 2025), $161756.0 (Q3 2025), and $126820.0 (Q2 2025), per Business Quant data.